In Brief
Hemagglutinins (HAs) from the two influenza A subtype groups have similar structures, but cross-reacting serum antibodies are rare. McCarthy et al. nonetheless found, in three donors, abundant cross-group B cell receptors (BCRs), many with epitopes on the HA head. Members of one clonal lineage had a BCR structure similar to that of a previously described, genetically unrelated antibody. Serial responses to seasonal influenza appear to have elicited the lineage and driven affinity maturation. Appropriate immunization regimens might elicit comparable responses.
INTRODUCTION
The natural history of human influenza viruses in the 20 th and 21 st centuries reflects the appearance of novel serotypes by transfer from avian or porcine reservoirs, alternating with periods of gradual antigenic change, during which each newly introduced virus evolves to reinfect previously immune individuals (Kilbourne, 2006; Smith et al., 2004) . The immune repertoire of individual humans is largely the result of repeated exposures to evolving influenza viruses, beginning with infection (or recently, vaccination) early in life. The first exposure imprints the antigenreceptor (BCR) repertoire of memory B cells (Bmem) and influences subsequent responses to influenza variants, owing to the combined effects of clonal selection during the primary response and subsequent recall and somatic evolution of cross-reactive Bmem cells following later infection or vaccination (Andrews et al., 2015; Fish et al., 1989; Fonville et al., 2014; Jensen et al., 1956; Lingwood et al., 2012; Pappas et al., 2014; Schmidt et al., 2015a) . This history can be reconstructed from analysis of antibody clonal lineages (Lingwood et al., 2012; Pappas et al., 2014; Schmidt et al., 2015a) . Rapid adaptation of the circulating influenza virus strain to resist prevalent immune responses results in a virus-antibody (Ab) evolutionary ''arms race,'' in which herd immunity selects for viral variants that escape neutralization and those variants in turn drive selection of somatically mutated B cells and Abs that overcome viral escape. We have shown in previous work that B cell clonal lineages from a single individual can illustrate the history of this arms race in the broader population Schmidt et al., 2015a) . The hemagglutinin (HA) of type A influenza virus, the more dominant of its two surface antigens, defines 18 serological subtypes, which fall into two evolutionarily distinguishable groups. Since 1977, viruses of two HA subtypes have co-circulated in human populations. The HAs of group 1 (of which the circulating H1 subtype is a member) and group 2 (e.g., the circulating H3 subtype) influenza viruses have very similar structures, but Abs that bind HAs from both groups are rare, even for epitopes that are functionally constrained and conserved, such as the receptor binding site (RBS) and the HA ''stem'' (Corti et al., 2011; Dreyfus et al., 2012; Kallewaard et al., 2016; Nakamura et al., 2013; Wrammert et al., 2011) . Identification of BCRs that recognize HA epitopes shared by group 1 and group 2 influenza viruses in three adult subjects after immunization with trivalent influenza vaccine (TIV) has allowed us to characterize an instance of the evolutionary arms race between influenza viruses and the B cell responses of their hosts. We studied the Bmem BCR repertoires of these subjects using Nojima cultures to determine BCR specificity and avidity for single Bmem cells and to infer in each subject a history of clonal evolution in response to serial exposures to influenza variants. This inferred history addresses questions relevant to understanding co-evolution of virus and host immune responses and to optimizing vaccination strategies. Are cross-reactive BCRs usually elicited by one serotype and ''broadened'' by subsequent exposure to another, related variant, and if so, does coexposure to multiple serotypes offer any advantage? What are the differences among the epitopes on antigens from different strains that are recognized by cross-reactive Abs and what are the features of the antigen combining site (Ab paratope) that permit avid recognition of disparate influenza HAs? Are crossreactive Bmem cells rare or common, and how closely does the Bmem BCR repertoire reflect that of serum IgG antibody? Answers to these questions are crucial for understanding how the humoral immune system generates and matures protective responses to influenza.
We show in the work reported here that a small but significant fraction (z14%) of HA-specific Bmem cells from three unrelated, healthy donors expressed H3 and H1 cross-reactive BCRs. Most of these cross-reactive BCRs (42/55; 76%) were specific for the RBS or other epitopes present on the head of the HA trimer. We characterized in detail a substantial clonal lineage (K03.1-12) comprising 12 members that avidly bind and neutralize both group 1 and 2 influenza viruses. The computationally inferred, unmutated common ancestor (UCA) of the lineage bound and neutralized H1 and H3 influenza viruses, demonstrating the capacity of germline BCRs to recognize the RBS of divergent influenza A subtypes. High resolution structural analysis of Ab-HA complexes showed that K03.1-12 lineage Abs contact the RBS through an extended HCDR3 loop. The interaction very closely resembled that of the RBS-directed paratope in a phage-display recombinant Ab, C05 . Although both AbC05 and the K03.1-12 lineage Abs bound the RBS identically, the V H , D H , and J H gene segments encoding these disparate Abs were not the same, suggesting that sequential exposure to seasonal HA variants might drive selection of common paratopic structures and that for some exposure sequences, such paratopes might afford protection against both H1 and H3 virus subtypes. Analysis of K03.1-12 lineage BCR affinities to historical HAs suggested that this lineage might have arisen in response to serial seasonal exposures to both HA serotypes, with a key event being the loss of the K133a residue in H1 HAs that occurred in 1995. These results suggest that appropriate immunization regimens could elicit comparably broad protection against infection by influenza A viruses.
RESULTS

Single-Cell Cultures of Human Bmem Cells Support Robust Proliferation and IgG Production
To obtain clonal IgG Abs from individual human Bmem cells, we adapted single-cell Nojima cultures , as previously optimized for bulk expansions of human B cells . We isolated CD19 + CD27 + CD24
hi IgM À IgD À Bmem cells (Carsetti et al., 2004) from peripheral blood mononuclear cells (PBMCs) ( Figure 1A ) and cultured them on monolayers of MS40L-low feeder cells expressing human CD154 Su et al., 2016) . With the addition of human interleukin 2 (IL-2), IL-4, IL-21, and B cell activating factor (BAFF), this culture system supports B cell proliferation, Ig class-switch recombination, and differentiation into plasmablasts ( Figure 1B ). Thus, each culture supernatant contained a clonal IgG secreted by the differentiated progeny of individual Bmem cells ( Figure 1C ). In culture, single Bmem cells multiplied to z800 cells by day 13 and then increased logarithmically to generate an average of 90,000 daughter cells by day 25 ( Figure 1B) . In some culture supernatants, we detected clonal IgGs as early as day 16; IgG concentrations rose to an average of 50 mg/ml by day 25, with 56% of single B cell culture supernatants containing > 100 mg/ml IgG ( Figure 1C memory cell per well (Figures 2A and S1A ). Clonal IgGs that were later secreted into culture supernatants were individually screened against a panel of 10 rHA proteins in a multiplex bead assay ( Figure 2B and Figure S1B ). From a total of 874 IgG + wells (66% cloning efficiency), we identified 402 (46%) clonal IgGs with detectable affinity for the H3 Wi-05 rHA used in sorting. For both KEL01 and KEL03, avidity indices (AvIns; relative to the Ab2210 standard) for clonal IgGs clustered about a single, high-avidity peak that accounted for > 65% of the H3 + IgG + cultures ( Figure 2C ). A lower avidity tail (AvIn < 2.2) was also present ( Figure 2C ), as previously observed in mice immunized with an H1 rHA antigen . For KEL06, avidity indices for clonal IgGs clustered about an intermediate-avidity peak, which accounted for > 65% of the H3 + IgG + Bmem ( Figure S1C ).
Despite these differences in the distributions of AvIns for H3 + IgG + Bmem cells, serum titers against a panel of HAs were comparable for all three donors ( Figure S2 ).
The screening panel included HAs from seasonal H3N2 viruses (in addition to H3 Wi-05), seasonal and new Table S1 .
pandemic H1N1 viruses, an H5N1 virus, and an influenza B virus (Figures 2B and 3A and S1B) . Most KEL01 Bmem cells (89/91) were specific for H3 WI-05 and other H3 subtypes, but two (2/91; 2%) avidly bound H3, H1, and H5 HAs, and one of these also bound B Malaysia HA (Figure 3A) . Similarly, most Bmem clones from donor KEL03 were H3 specific (217/262), but 13% of them (35/262) also bound H1 (35/35) and H5 (3/35) HAs ( Figure 3A) ; a third subset of Bmem clones (10/262) bound only weakly to H3 HAs but more avidly to HAs from non-H3 serotypes ( Figure 2B ). Over one-third of the H3 + IgG + Bmem cells (18/49) from KEL06 also bound HAs from other subtypes: H1 (18/18), H5 (2/18), and B (1/18) ( Figure 3A ). All the crossreactive Bmem clones were HA specific and had little or no affinity for other protein antigens ( Figure S3 ). We further clustered crossreactive clonal IgGs by their patterns of reactivity with our panel of 10 rHAs ( Figure 3A) . The panel included two head-only constructs, which distinguish between antibodies that bind the HA head domains and those that bind elsewhere (''non-head''). Most of the crossreactive Bmem clones (35/37) from KEL01 and KEL03 reacted with the head of H3 WI-05 or H3 A/Johannesburg/3/1994 (H3 Jo'burg-94) or with both; the epitopes of crossreactive Bmem clones from KEL06 were more evenly distributed between head (7/18) and non-head (11/18) ( Figure 3A and Table S1 ). Of the headdirected, H3/H1 crossreactive clonal IgGs from the three donors, half (23/42), all from KEL03, inhibited binding of an RBS-specific monoclonal Ab, CH67 Whittle et al., 2011) , to the H1 A/Solomon Islands/3/2006 rHA (''H1 SI-06'') ( Figure 3B ) and hence bound epitopes proximal to the RBS. We conclude that a significant fraction (2%-37%) of HA-specific human Bmem clones recognized HAs from multiple influenza serotypes and that a substantial part of this cross-reactivity was for HA-head epitopes.
Broad BCR Diversity of H3 and H1 Cross-Reactive Human Bmem Cells We amplified and sequenced heavy-and light-chain V(D)J rearrangements from the cross-reactive Bmem cell clones Tiller et al., 2008; Wardemann et al., 2003) . No V(D)J rearrangement from a crossreactive Bmem cell was unmutated; V H gene segments differed from their germline sequences by 4 to 38 point mutations, and V L gene segments, Figure S4 ). The H3 and H1 crossreactive Bmem cells from KEL03 (n = 35) comprised five clonal lineages, containing between 2 and 12 members, and 7 singletons, and those from KEL06 (n = 18), two clonal lineages, of 2 and 4 members, respectively, and 12 singletons ( Figure S4 ). A total of 20 different V(D)J rearrangements were represented among the 28 distinct lineages and singletons from the three donors ( Figure S4 ). The light-chain distribution was also broad ( Figure S4 ). Thus, group 1 and group 2 crossreactive BCRs expressed by the cloned Bmem cells were genetically diverse, using different V H and V L gene segments to recognize epitopes shared by multiple HA subtypes.
Characterization of a Lineage of Cross-Group Binding Human Bmem Cells and Its UCA
The 12 member K03.1-12 lineage ( Figure 4A ) of H3/H1 crossreactive Bmem cells had distinctive features, including strong inhibition of CH67 binding and high avidity for both H3 WI-05 and H1 SI-06 HAs (Figure 3) . We inferred the BCR of the lineage unmutated common ancestor (UCA), or presumptive founder, to have been encoded by rearrangements of IGHV1-2, IGHD6-19, and IGHJ6 and paired with IGLV2-23 joined to IGLJ2; the inferred UCA has an unusually long, 26-residue HCDR3 ( Figure S4 and Supplemental Datasets 1 and 2).
We generated recombinant Abs (rAbs) representing key members of the K03.1-12 clonal lineage, including the UCA, for detailed characterizations of BCR specificity, affinity, and neutralization activity . We screened Fabs of the K03.12 UCA, three inferred evolutionary intermediates Descendants of the UCA also bound heads of viral isolates that were not bound by the UCA (Figure 4B ). Neutralization assays gave similar results (Table S2) . Neither the UCA nor K03.12 neutralized viruses that circulated before 2005. These data suggest that the UCA had the potential to bind both H3N2 and H1N1 HAs and that this property persisted during subsequent periods of affinity maturation. donor ( Figure 5A ). Contacts between Fab and HA were almost exclusively through the 26-residue HCDR3, the only exception being Glu 52 in LCDR2, which contacted Leu 157 (van der Waals contact) and Asn 158 (hydrogen bond) in HA. Ten residues of HCDR3 (103 to 112) formed an extended b-hairpin. Contacts with HA were principally with residues conserved (or conservatively substituted) in all H1 and H3 isolates-Tyr 98, Ser 136, Trp 153, Thr 155, Asp 190, and Leu 194 (Figure 5B) . Moreover, main-chain hydrogen bonds with HCDR3 contributed a substantial component of the interaction, making binding less sensitive to the amino-acid sequence in HCDR3 than might otherwise be the case. For example, contacts that mimicked those from the carboxylate and acetamido groups of sialic acid (Schmidt et al., 2015b; Whittle et al., 2011) were with carbonyl 109 (with Ser 136) and the amide and carbonyl groups of residue 110 (augmenting the b hairpin of HCDR3 by an antiparallel b-interaction with HA residue 135).
We also determined the structure of the UCA Fab bound with the HA head domain from H1 SI-06 ( Figure 5C ). The contacts between the UCA HCDR3 and the H1 HA were essentially the same as those between K03.12 and the H3 HA ( Figures 5D and S6) , and the ''footprints'' of the two rAbs on HA were nearly identical.
The two structures show why members of the K03.1-12 lineage bound HAs of H1N1 viruses that circulated after about 1995 and why they failed to bind the new pandemic H1N1. The 1918 H1 HA, most of its descendants, and the 2009 new pandemic have, with respect to H3 HAs, an ''extra'' residue, conventionally numbered 133a, at the rim of the RBS. This residue displaces the strand between residues 131 to 135 with respect to its conformation in H3 HAs and in H1 HAs that lack it; that displacement is incompatible with the observed positions of the HCDR3 in the two structures (Figure 6 ). Insertion of K133a into the H1 SI-06 HA eliminated binding of K03.1-12 lineage-member Fabs ( Figure 4B ). Deletion of K133a in some pre-1995 HAs was not, however, sufficient for high affinity of K03.12 or its UCA, nor were all post-1995 HAs that had lost the 133a residue high affinity antigens ( Figure 4B) .
A hinge at the base of the HCDR3 b-hairpin, allowed K03.1-12 lineage antibodies to adapt to a relative shift of the H1 and H3 HA backbones at residue 133 without changing essential HCDR3 contacts. Although nearly all H1 HAs that circulated before 1995, as well as those of the 2009 pandemic and nearly all H5 HAs, have the 133a insertion, loss of residue 133a from H1 HAs did not lead to full coincidence of their polypeptide chain backbones with those of H3 HAs (Figure 6 ). Local sequence regularities cannot account for this consistent displacement, which appears to relate to a loop (residues 122-125) in HAs of group 1, absent in HAs of group 2, and with the identity of residue 152 (Asn in H1s; Leu in H3s). The 122-125 loop in H1 covers the hydrophobic Leu 152; absence of the loop favors a more polar residue, such as Asn 152, which in turn favors the ''H3-like'' configuration of the polypeptide-chain backbone at the 132-133 peptide bond by accepting a hydrogen bond from the position 133 main-chain amide (Figure 6 ). Indifference to these configurational variations will be a crucial property of any cross-reactive, RBS-directed antibody. The two branches of the K03.1-12 lineage had very different mutation frequencies-an average of about 7% in the I-10 branch and about half that in the I-4 branch while ratios of non-synonymous substitutions were similar in both branches ( Figure S4 ). Differences in mutation density were already apparent in the intermediates, I-10 and I-4, that defined the two branches. Members of the I-10 branch bound H3 HAs more tightly than did members of the I-4 branch, a trend that could be seen in the H3-Wisconsin AvIn screen (Figures 3  and 4B) . Conversely, members of the latter branch bound H1 HAs more avidly than did members of the former. Moreover, the affinity of K03.12 for H1 HAs was somewhat lower than that of its ancestors, I-10 and I-11. These comparisons suggest that H3 exposures might have driven affinity maturation and proliferation in the I-10 branch, and that H1 exposures might have driven the I-4 branch. At position 111, members of the I-4 branch retained a Glu residue in contact with the conserved Ser 145 in H1 HAs; the Glu111Ala mutation in the I-10 branch might reflect selection by the slightly larger Asn at the same position in most post-1975 H3 HAs. The re-introduction of K 133a in the new H1N1 pandemic of 2009, eliminating binding by any of these Abs, might account for the diminished affinity maturation in the H1-preferring I-4 branch and the continuing evolution in the H3-preferring I-10 branch.
Comparison of K03.12 with Ab C05
We found that the HA contacts of K03.12 were remarkably similar to those of a previously reported phage-library rAb, designated C05 (Figure 7) . Although their heavy chains derived from completely different gene segments, both rAbs had HCDR3 loops of the same length and related amino acid sequence. Their respective N-nucleotide sequences were very different, as expected for Abs that arose independently in different individuals ( Figure S6 ). Nonetheless, sialic-acid-like contacts were essentially identical. Both Abs had a Trp at position 110 (100f in the C05 numbering), inserted in similar conformation into the hydrophobic slot between Trp 153 and Leu 194, where the acetamido methyl group of the sialic-acid receptor fits (Figure 7) ; both antibodies contacted HA residues 134-136 and Tyr 98 through homologous main-chain hydrogen bonds. C05 also shared with the UCA and the I-4 branch of the K03.1-12 lineage a Glu at position 111, which received a hydrogen bond from HA Ser145. The natural pairing of the C05 heavy chain is unknown, but the absence of substantial HA contacts from the light chain of either C05 or K03.12 probably allowed their heavy chains to be relatively promiscuous in light-chain association. The critical HA contacting residues (100c-100f) in the C05 HCDR3 were encoded primarily by N-nucleotides; the corresponding residues in the K03.1-12 lineage (107-110) were encoded by the human IGHD 6$19*01 gene segment ( Figure S7 ). Thus, both the human germline repertoire and junctional diversity can produce K03.1-12-like Abs with the capacity to neutralize group 1 and group 2 influenza viruses.
DISCUSSION
Nojima cultures, used here to analyze human responses to a TIV, are effective alternatives to single B cell sorting and V(D)J amplification and sequencing Wardemann et al., 2003) . The efficacy of Nojima cultures is especially evident when seeking BCRs that are difficult to identify by flow cytometry because of their complex paratopic profiles (e.g., binding to several distinct antigens) or because they represent only a minor component of the B cell repertoire. The secretion of substantial quantities (> 50 mg/mL) of clonal IgG into Nojima culture supernatants of human Bmem cells permits rapid and repeated screening for BCR/IgGs with complex BCR binding profiles. Consequently, one can restrict V(D)J sequencing and recombinant IgG expression to just those BCRs of interest, having allowed the cloned B cells to do most of the work. Circulating influenza A viruses transmitted from one human to another recognize an a-2,6 linked sialic acid receptor (Skehel and Wiley, 2000) , and their receptor binding sites are correspondingly conserved, even across subtypes. Nonetheless, heterosubtypic, RBS-directed Abs have appeared only infrequently in published studies of the human B cell repertoire. The K03.1-12 lineage, inferred from the V(D)J sequences from 12 heavy and light-chain pairs recovered from single-cell Nojima cultures, offers a good opportunity to define specifically the antigenic 'barriers' that separate group 1 and group 2 HAs.
The presence of residue 133a adds a bulge to the backbone conformation on the lateral edge of the RBS, but there a consistent difference at position 133 between H3 HAs and even those H1 and H5 HAs that lack residue 133a. The lineage of any RBSdirected antibody sensitive to this difference may fail to develop heterosubtypic breadth, even after repeated exposure to HAs of the heterologous group. The adaptability of Abs in the K03.1-12 lineage might come from configurational flexibility at Gly 113, which has a negative f torsion angle in the K03.12 complex with an H3 HA and a positive one in the UCA complex with an H1 HA, allowing the C-terminal side of HCDR3 to move away from residue 133 in the latter. C05 has an Ala at the position corresponding to 113, but the configuration of its polypeptide chain at the C-terminal end of HCDR3 suggests that the Fab could bind H1 HAs with only a small adjustment of the configuration seen in the published X31 (H3) complex . Neither C05 nor members of the K03.1-12 lineage can bind HAs bearing residue 133a (e.g., the new pandemic A/California/07/2009).
Another characteristic difference between group 1 and group 2 HAs is the identity of residue 226 (Lin et al., 2012) , which is also a key site of change when avian viruses adapt to human receptors (Rogers et al., 1983) . The UCA HCDR3 avoids this residue in its complex with Gln 226 in H1 SI-06, and K03.12 itself has a single van der Waals contact with Ile 226 in H3 TX-12. Lineage members can also bind H1 HAs with Arg 226, an adaptation to growth in eggs found in some vaccine strains .
The affinities of K03.1-12 lineage Fabs for HAs from virus isolates circulating during the donor's lifetime suggest two alternative histories for their elicitation and affinity maturation. The earliest HA in our panel that binds the K03.1-12 lineage UCA Fab is an H1 from the year 2000. The structures show that the presence of residue 133a in H1 HAs is incompatible with binding by K03.1-12 lineage members and hence that if the eliciting exposure was to an H1 HA, the primary response was unlikely to have occurred before 1995-the antigenic cluster transition that accompanied 133a loss. The affinities for H1 HAs of K03.12, K03.1, and lineage intermediates increased between 2000 and 2006, but so did the affinity of the UCA, showing that the increases were due primarily to mutational changes in the HAs, not in the antibodies. For H3 isolates, however, the relative affinities of various lineage intermediates probably do reflect ongoing affinity maturation. Thus an alternative history of the lineage invokes a subdominant response to an H3 virus, perhaps during the donor's childhood (e.g., 1975-1980) . Loss of residue 133a from H1 HAs-and hence emergence of a more H3-like epitopic contact-could then have stimulated clonal expansion in the late 1990's, followed by a further wave of affinity maturation against H3s after 2009. A suspected influenza infection around the year 2000, reported by donor KEL03, might have accounted for the former, H1-based diversification. Our earlier analysis of GC B cells in mice immunized with HA showed both a diversifying repertoire in primary GCs and retention of lower avidity clones . Both observations suggested that the response to complex antigens might have evolved to retain a heterogeneity of avidities and a diversity of epitopic specificities, to optimize protection against subsequent exposures to antigenic variants of a pathogen.
The congruence of the C05 and K03.1-12 HCDR3 loops is a striking example of two essentially identical antigen combining sites in BCRs from unrelated donors. That we found this convergent evolution in a relatively small sample of Bmem cells suggests that the H3 and H1 cross-reactive BCR paratope is not particularly rare. Unlike VRC01-like Abs that react with the HIV-1 RBS (Zhou et al., 2010) , the K03.1-12 paratope that interacts with the RBS of H1 and H3 HAs is not a germline-encoded element but part of an HCDR3 loop encoded, at 11 of its 26 amino-acid residues, by N-nucleotides. The 26-residue HCDR3 is about 10 residues longer than the mean length of human HCDR3s and therefore thought to be disfavored (Willis et al., 2016 ). An extensive study of long HCDR3 sequences in a cohort of adult, HIV-naive donors found a frequency of about 1% for 26-residue HCDR3s, with a bias toward J H 6 encoded J-segments (as in K03.12) and about a 4% representation of IGHD 6-19 encoded D-segments (with two possible open reading frames) (Willis et al., 2016) . The probability of finding a K03.12-like antibody among the corresponding 0.02% of all BCRs in an individual will thus depend on how restrictive are the requirements for particular amino-acid residues at particular N-nucleotide encoded positions in the loop. The high proportion of backbone (rather than side-chain) interactions with the HA RBS, suggest that potential germline precursors of K03.1-12-like Abs could be present in most human naive B cell repertoires. We searched for KEL03.12-like HCDR3 sequences among BCR sequences from a cohort that received the 2008 TIV (Jackson et al., 2014) . The cells from five of the 14 subjects yielded least one sequence encoding a long HCDR3 similar to that of KEL03.12, and five of the seven KEL03.12-like sequences identified were from cells isolated at various intervals following vaccine administration.
In all three of the normal donor samples analyzed by Nojima cultures, we found a cross-reactive BCR phenotype with substantial representation (2%-37%) among H3-binding Bmem cell clones; most (76%) recognized HA head epitopes. The relative abundance in these individuals of human Bmem cells that cross-reacted with the HA head from group 1 and group 2 influenza contrasts with results of a recent study (Joyce et al., 2016) in which Bmem cells cross-reacting with HAs from group 1 and group 2 influenza A were found to be specific for stem epitopes. (this work). The RBS of our H3 probe is not only very similar to the corresponding site on the H3s that imprinted and updated these individuals' repertoires, but it is also more similar to the H1 RBS in viruses circulating since 1995 than it is to those of H5 or H7 (or essentially any other avian strain). The affinity of an H1 or H3 imprinted repertoire for the RBSs of H5 and H7 might have been too low for robust detection in the sorting step. Moreover, stem-directed Bmem cells appear to be in low abundance in most individuals, probably because on the virions that would have elicited the imprinting response during a childhood infection, the stem is relatively inaccessible. Therefore, in an H3 sort, RBS-directed Bmem BCRs present at the time of vaccination would probably have dominated the crossreactive component of the Bmem cells detected. In an H5 plus H7 sort, however, the stem would be the only epitope similar enough to those on H1 or H3 HAs to yield a positive signal. (2) The fluorescent H3-HA that we used to isolate Bmem cells had a wild-type RBS instead of a modified ''bait'' with a mutation (Y98F), introduced to eliminate sialic-acid binding and hence prevent the staining of non-HA binding cells (Whittle et al., 2014) . Y98 contacts KEL03.12 and other RBS directed antibodies. It is possible that this mutation might have prevented or diminished the labeling of HA-head reactive cells. (3) A further difference between the studies is analysis of only expanded clonal lineages (Joyce et al., 2016) versus analysis of all HA-binding clones (this work). The nearly equal representation of head-and non-head directed H3/H1 crossreactive Bmem cells from donor KEL06 shows that we could readily identify both. (4) Finally, there were distinct exposure histories by vaccination or infection of the disparate donors in each study. Regardless of these methodological differences, our results show that the human immune system can provide protection against divergent influenza A virus types through common epitopes that are present on the HA head, as well as through those on the stem. At least one of these common epitopes is the RBS.
The relative abundance of human Bmem cells expressing H3/H1 cross-reactive, head-directed BCRs contrasts with the infrequent detection of crossreacting serum antibodies reported in the literature (Corti et al., 2011; Dreyfus et al., 2012; Kallewaard et al., 2016; Nakamura et al., 2013; Wrammert et al., 2011) . It is possible that distinct compartments of the humoral response-here, Bmem cells and the plasmacytes that produce serum antibody (Nutt et al., 2015) -do not generally reflect a common BCR repertoire. If so, analyses of serum antibody reactivity against influenza HAs might not report the full spectrum of BCR specificities in Bmem populations elicited by infection or vaccination. Indeed, serum IgG antibody for H3 WI-05 did not reflect differences in the distributions of AvIns for HA H3 WI-05 reactive Bmem cells recovered from the KEL01, À03, and À06 donors. High affinity BCRs promote differentiation of GC B cells into long-lived plasmacytes, while GC B cells with lower affinity receptors enter the Bmem compartments (Kr€ autler et al., 2017; Phan et al., 2006) . This selection might be driven by intrinsic differences in BCR signaling or might reflect a ''temporal switch'' in the GC reaction that favors generation of long-lived plasmacytes late in the GC response (Weisel et al., 2016) . These differences suggest that the Bmem pools sampled by Nojima culture might represent populations that are less avid but more crossreactive than BM plasmacytes.
The course of affinity maturation in the two branches of the K03.1-12 clonal lineage indicates that donor KEL03 experienced a succession of exposures to influenza A viruses (or vaccine HAs) of both subtypes. We note the HAs used to pan for C05 were similar to those used in this study: H3-Wisconsin and A/New Caledonia/20/1999 (H1N1), an H1N1 virus that also lacked the K133a insertion. In these examples, selection for binding to similar HAs resulted in a common solution. This result shows that a suitably chosen sequence of vaccine immunogens might favor a similar heterosubtypic response (Haynes et al., 2012) .
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Subject Details
Peripheral blood mononuclear cells (PBMCs) were obtained from three human (Homo sapiens sapiens) subjects under Duke Institutional Review Board committee guidelines. Written informed consent was obtained from all three subjects. Human subjects are designated KEL01 (male, adult, age 39), KEL03 (female, adult, age 39) and KEL06 (female, adult, age 35).
Cell Lines
Human embryonic kidney (HEK) 293T cells were maintained at 37 degrees Celsius with 5% CO 2 in DMEM supplemented with 10% FBS, penicillin and streptomycin. Human 293F cells were maintained at 37 degrees Celsius with 5% CO 2 in FreeStyle 293 Expression Medium (ThermoFisher) supplemented with penicillin and streptomycin. MS40L-low feeder cells (Mus musculus) were expanded from frozen aliquots in Iscove's Modified Dulbecco's Medium (Invitrogen) containing 10% HyClone FBS (Thermo scientific), 2-mercaptoethanol (5.5 3 10 À5 M), penicillin (100 units/ml), and streptomycin (100 mg/ml; all Invitrogen) at 37 degrees Celsius with 5% CO 2 Su et al., 2016) . Madin-Darby canine kidney cells (MDCK) (Canis lupus familiaris) were maintained in DMEM at 37 degrees Celsius with 5% CO 2 . High Five Cells (BTI-TN-5B1-4) (Trichoplusia ni) were maintained at 28 degrees Celsius in either EX-CELL 405 medium (Sigma) supplemented with penicillin and streptomycin or Express-Five (Thermo Fisher) medium supplemented with L-glutamine (GIBCO) at a final concentration of 16 mM, penicillin and streptomycin. Cell lines were not subject to authentication.
Subject-Derived Cells
Human Bmem cells were expanded in the presence of MS40L-low feeder cells as described Su et al., 2016) , wth the following modifications. Single human Bmem cells were directly sorted into each well of 96-well plates and cultured with MS40L-low feeder cells in RPMI1640 (Invitrogen) containing 10% HyClone FBS (Thermo scientific), 2-mercaptoethanol (5.5 3 10 À5 M), penicillin
Neutralization Assays
Monoclonal antibodies were diluted to test concentration in assay diluent and evaluated as duplicate two-fold dilutions series. The 50% neutralization EPT for a given sample is reported as the geometric mean of duplicate dilution series.
DATA AND SOFTWARE AVAILABILITY
V(D)J sequences for the 12 members of K03.12 lineage are available at GenBank (www.ncbi.nlm.nih.gov/Genbank), accession numbers KY778717-KY778740. Coordinates and diffraction data have been deposited at the PDB, accession numbers 5W08 and 5W0D.
